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ABSTRACT
Objectives To identify pregnant women’s views and 
attitudes towards maternal immunisation in Panama based 
on in- depth interviews and focus groups.
Setting Two main urban centres in Panama (San Miguelito 
and Panama City).
Participants Fifty- six pregnant women from Panama City 
(n=29) and San Miguelito (n=27).
Methods In- depth interviews and focus groups were 
conducted, audio- recorded, transcribed verbatim and 
analysed using a deductive- inductive approach.
Results Our findings suggest that this population 
perceives vaccination as a key component of maternal 
healthcare, not an elective part of it. The pregnant 
women interviewed disclosed a heightened perception 
of vulnerability to infectious diseases. For this reason, 
safety and effectiveness of maternal vaccines were 
closely associated for many participants (a vaccine was 
perceived as safe if it was effective against disease). 
Refusal of maternal vaccination was strongly associated 
with parental negligence. Participants reported the 
participation of husbands and partners in the decision- 
making around their health. Most participants reported 
high information- seeking behaviour, particularly online; 
many interviewees confirmed any information obtained 
online with their healthcare professionals (HCPs). Vaccine 
recommendations from HCPs appeared to be one of 
the main predictors of maternal immunisations among 
the sample interviewed. While acceptability of maternal 
vaccines was high in this sample, some pregnant women 
expressed concerns and doubts (e.g., that maternal 
vaccines could cause miscarriages) which require 
attention. Finally, many participants reported difficulties in 
accessing maternal vaccination, pointing to financial and 
physical barriers.
Conclusions The acceptability of maternal immunisation 
was high among the interviewed women. The pregnant 
women’s receptiveness to maternal vaccinations, even 
when information provided was limited, is suggestive of 
high levels of trust in HCPs. Even so, HCPs and health 
officials should remain alert to apprehensions expressed 
by pregnant women. Many participants reported struggles 
in accessing maternal vaccination, pointing to issues that 
merit further examination.
INTRODUCTION
Maternal immunisation is key to achieving 
the United Nations Sustainable Develop-
ment Goal of reducing maternal and child 
mortality.1 The Latin America and the 
Caribbean (LAC) region is a global leader 
in maternal and neonatal immunisation as 
evidenced by the elimination of congenital 
rubella syndrome and strong progress made 
towards neonatal tetanus elimination, both of 
which were achieved through successful vacci-
nation programmes. Adding to these achieve-
ments in maternal health, 31 LAC countries 
currently target pregnant women for influ-
enza vaccination and, as of 2015, aim to vacci-
nate over 90% of the region’s newborns with 
hepatitis B vaccination.2
Panama, a high- income LAC country 
located in Central America, has been one 
of the fastest growing economies in the 
world, with a growth rate of 4.6% in the past 
5 years.3 The country has a population of 
approximately 4.4 million people as of 2021,4 
and indigenous people comprised 12.2% of 
Strengths and limitations of this study
 ► This is the first qualitative study to date to identify 
themes associated with maternal vaccine accep-
tance in Panama.
 ► We recruited a diverse sample of pregnant women in 
San Miguelito and Panama City.
 ► We analysed the data using a rigorous, deductive- 
inductive approach.
 ► The findings, however, may not be generalisable. 
Instead, the findings relay experiences of par-
ticipants which may not be found in quantitative 
studies.
 ► Our sample was limited to urban populations; future 
studies should elicit the perspectives of rural and 
indigenous groups.
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the population in 2010.5 Adding to its large indigenous 
population, Panama is ethnically and culturally diverse, 
in large part due to its prominent role in international 
trade. Panama is one of the many Latin American nations 
with a sizeable West African diaspora, stemming from 
when slaves were forcefully brought in for the mining 
industry. Later, the construction of the Panamanian Rail-
road and eventually the Panama Canal, attracted workers 
from around the world, including Asia, Europe and the 
Caribbean—as well as US troops, who oversaw the use of 
the canal for over two decades.6
Health system configuration and Panama’s National 
Immunization Programme
Panama’s public health system is managed and provided 
by the Ministry of Health (Ministerio de la Salud) and Social 
Security Services (Caja de Seguro Social). It is estimated 
that 90% of the population have access to public health 
services: there are subsidies available for low- income 
populations, mostly concentrated in rural areas, who 
are not registered with Social Security Services. Despite 
efforts to tackle socioeconomic determinants of health,7 
marked health inequities remain, particularly between 
urban and rural populations. Weak health infrastructure, 
economic inequality and geographic barriers of economic 
and geographic nature all contribute to deficient access 
and lower health outcomes among indigenous and rural 
populations. In fact, while the maternal mortality ratio 
for Panama is moderate with 41.6 deaths per 100 000 live 
births, in some indigenous areas the death rate can be as 
high as 658 per 100 000.7
Panama has one of the best vaccination programmes in 
the LAC region.3 The National Immunization Programme 
(Programa Ampliado de Inmunizaciones) was created in 1978, 
with an initial focus on childhood vaccinations before 
expanding to cover adult immunisation. Currently, 
Panama offers 23 different vaccines protecting against 
30 diseases.8 In line with Pan- American Health Organiza-
tion recommendations, Panama offers all recommended 
maternal vaccines free of charge, including routine Tdap 
immunisation to pregnant women, which is only made 
available by a few other countries in the region. Along-
side such countries, Panama has the potential to evaluate 
its impacts and contribute to informing decision- making 
in the region.2
LAC barriers to maternal immunisation and Panama
While there has been significant progress towards 
improving maternal immunisation coverage in Latin 
America, great discrepancies in vaccination uptake still 
exist. Across countries, coverage rates may vary dras-
tically—and within countries, there can be persistent 
heterogeneity for coverage between regions, even in coun-
tries with high national coverage.9 According to Guzman- 
Holst et al, in their comprehensive literature review of 
barriers to vaccination in LAC, only three studies (5% of 
total included in the review) looked at barriers to vaccina-
tion among pregnant women: Mendonza- Sassi et al10 and 
Kfouri and Richtmann11 investigated factors associated 
with influenza vaccine coverage among pregnant women 
in Brazil; Ozaki and Shimo12 surveyed pregnant women 
about perceptions of a rubella vaccine.
While there have been some qualitative studies in 
Panama investigating overall vaccine acceptance,5 13 little 
is known about perceptions of maternal immunisation 
among pregnant women in the country. The present 
study investigates views and attitudes towards maternal 




This study is part of a larger global research project inves-
tigating attitudes to maternal vaccination worldwide. 
The study included participants from Panama City and 
the adjacent city of San Miguelito. The two cities were 
selected for several reasons. First, they are two of the most 
populous cities in the country, located in the centre of 
the country near the Panama Canal. Second, the two 
locations were chosen to allow comparisons of differ-
ences in interactions with the healthcare system, with a 
greater concentration of financial resources, hospitals 
and healthcare services in Panama City. Third, both cities 
have high urban demographic concentration which can 
facilitate virus contagion and outbreaks.
Recruitment
In total, 56 pregnant women from Panama City (n=29) 
and San Miguelito (n=27) participated in this qualitative 
study. The ages of the participants ranged from 18 to 39, 
with an average age of 26 years. Half of the participants 
(n=28) were first- time mothers. All recruiting was done 
face- to- face; in both Panama City and San Miguelito a 
trained recruiter was sent to hospitals, healthcare centres 
that provide antenatal care, private clinics and maternity 
hospitals to recruit participants. No chain or snowballing 
recruitment methodology was used. To be included in the 
study, participants had to be pregnant at time of partici-
pation and at least 18 years old.
To ensure a diverse sample of positive and negative atti-
tudes towards vaccines, the screening process included 
one question about acceptance of maternal immunisa-
tion: ‘On a scale of 1–10, could you tell me how strongly 
you agree or disagree with this statement, where 10 is 
agree completely and 1 is disagree completely: ‘I would 
take any vaccine recommended to me by a doctor’’. The 
sample was selected to ensure a mix of responses to this 
question: 25% of participants (n=14) responded 1–3, 
41% (n=23) responded 4–7 and 34% (n=19) responded 
8 or more. All participants were compensated for travel, 
subsistence and participation in the research. Recruit-
ment was continued until data reached saturation and no 
additional issues or insights emerged from the data.14
Data collection
Primary data were collected by staff at Worldwide Inde-
pendent Network/Gallup International Association 
3Simas C, et al. BMJ Open 2021;11:e044903. doi:10.1136/bmjopen-2020-044903
Open access
(WIN/GIA), who conducted in- depth interviews and 
focus groups, in Spanish, under the supervision of CS. 
Data collectors were experienced local professionals 
briefed on the overall objectives of study. Data collection 
took place between April and May 2019 in Panama City. 
Two topic guides were developed, one for in- depth inter-
views (online supplemental file 1) and another for focus 
groups (online supplemental file 2). They were written 
in a way to encourage participants to discuss their views 
and opinions freely. In- depth interviews investigated indi-
vidual perceptions and allowed exploration of sensitive 
topics. Focus groups explored shared representations and 
how different perceptions were negotiated among peers. 
Data generated from focus groups informed how shared 
values, social norms and group dynamics might impact 
maternal vaccine confidence; data from individual inter-
views provided in- depth understanding of reasons for atti-
tudes towards maternal vaccination. Audio files of focus 
groups and interviews were translated and transcribed 
from Spanish directly into English by a professional trans-
lator at WIN/GIA.
In-depth interviews
Twenty in- depth interviews were conducted in Spanish 
with pregnant women, either face- to- face or over the 
phone. Due to mobility limitations from advanced preg-
nancy, the option of participating over the phone was 
given to participants. When face- to- face interviews were 
possible, data collection took place at the offices of WIN/
GIA subsidiaries in Panama City and participants from 
San Miguelito travelled to participate. Most interviews 
conducted in person were observed and supervised by CS.
Focus groups
Four focus groups were conducted (two per location). 
Each group was composed of 8–10 women of different 
ages and stages of pregnancy. Groups were split into first- 
time pregnancies and non- first- time pregnancies. All 
focus groups required participants to attend in person 
and were conducted in Spanish at the country offices of 
WIN/GIA subsidiaries in Panama City. The focus groups 
were observed and supervised by CS. Participants were 
compensated for travel, subsistence and participation in 
the research.
Data management and analyses
To ensure confidentiality, all data were anonymised. 
Quotations from participants were used in this study and 
confidentiality was maintained by using city acronyms 
as sole identifiers (PC for Panama City and SM to San 
Miguelito); we ensured participants cannot be identified 
through contextual information.
Data were stored anonymously within a secure server 
on password- protected computers. Only co- investiga-
tors cited in the ethics approval had access to the files. 
As per the London School of Hygiene & Tropical Medi-
cine Records Retention and Disposal Schedule guid-
ance, research data will be stored for ten years, and the 
records documenting the management of the project 
will be stored for 6 years following the completion of the 
research study.
A deductive approach was used to develop an initial 
coding scheme based on research goals and interviews 
guides. The initial coding framework was piloted in a 
few transcripts and through an inductive process, addi-
tional codes were derived from deeper interpretation of 
data and analytical notes. Transcripts were analysed using 
NVivo V.11 software (QSR International, Melbourne, 
Australia). The results were organised under themes 
derived from the literature and which emerged when 
pregnant women were surveyed about different aspects 
of maternal immunisation. This study adheres to the 
Standards for Reporting Qualitative Research reporting 
guideline15 (online supplemental file 3).
Patient and public involvement
This research was done without public involvement.
RESULTS
Maternal immunisation as a social norm
Most participants of this study were positive about 
maternal immunisation. They perceived vaccines as 
something normal or routine to their lives. As one 
mother states, ‘Vaccinating is part of our culture, you 
just do it’ (PC). Another mother discusses this idea of 
normalcy associated with vaccines through a metaphor, 
‘To me, taking my children to get their shots is like giving 
them a bath—it’s just something that needs to be done’’ 
(PC). One mother boasted proudly, ‘‘I have never refused 
a shot!’’ (SM). Other participants, when asked why they 
chose to vaccinate, simply answered, ‘‘You have to do it 
(get vaccinated)’’ (PC); or ‘‘It is the right thing to do’’ 
(SM). Another mother echoed her peers, ‘‘(I got vacci-
nated because) everyone did it’’ (PC). Some talked about 
the ‘‘culture’’ of vaccination, ‘‘I haven’t heard anything 
bad about vaccinations after someone got a vaccine, and 
really when many people get the vaccination, it’s like a 
culture’’ (PC).
When probed about their decisions to take maternal 
vaccines, most of the women expressed there appears to 
be an overall sentiment that there is no decision to be 
made. To have vaccines, including maternal immunisa-
tion, is the normal, expected behaviour. ‘‘We feel it is a 
requirement, it’s not an option. You're due for a shot, 
you get the shot’’ (PC). Both general immunisation and 
maternal immunisation were perceived by most women 
as an important part of their healthcare routine, one that 
was not optional, ‘‘Getting vaccinated was not a decision 
(…), I believe it is part of the routine of being pregnant’’ 
(PC).
Influencers in health decision-making
When asked about their overall health decision- making, 
many of the women noted that their husbands, mothers 
and HCPs were involved in decision- making. In particular, 
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husbands and partners played a key role for many partic-
ipants. Several women interviewed discussed seeking 
support from partners, ‘‘My husband helps me make a 
decision’’ (PC); ‘‘My husband—he’s the one who takes 
the decisions for my pregnancy’’ (PC); “Since the begin-
ning it has been the two of us (husband and I). Him and I 
have always taken any decision together’’ (PC).
Many times, women described their own husband’s 
trust in medical advice, ‘‘He (my husband) doesn’t want 
me to take anything not prescribed by my doctor’’ (PC). 
Another shared that ‘‘(When making decisions) I ask him 
(husband), but I always go with what the doctor recom-
mends’’ (PC). One participant discussed a situation in 
which her husband refused for her to get vaccinated 
because he was uncomfortable with the man vaccinating 
her, ‘‘A friend of mine (did not get vaccinated because 
her) husband wouldn’t let another man touch her—
culture, and education levels (influence vaccination)’’ 
(SM).
Perceptions of disease risk versus perceptions of vaccine 
safety and effectiveness
A reason repeatedly cited for maternal immunisation was 
the high prevalence of infectious diseases in Panama. 
Participants had heightened perceptions of disease risk 
and felt vulnerable—and recognised that vaccines can 
mitigate such risk. Several of the interviewed mothers- 
to- be stressed the importance of vaccines, ‘‘because they 
protect children from viruses’’ (PC) and ‘‘because they are 
effective in protecting viruses’’ (SM). When asked about 
the benefits of immunisation and why she had been vacci-
nated, one mother stated, ‘‘(Vaccines) avoid diseases that 
could cause unfortunate consequences later. Better safe 
than sorry’’ (PC). Some women interviewed talked about 
the power of maternal vaccines, not only for themselves, 
but also for their unborn babies, ‘‘I’d say the benefit (of 
maternal vaccination) is that the baby gets vaccinated 
through the mother’’ (PC).
Some women associated safety with the effectiveness of 
vaccines. They reported perceiving vaccines as unsafe in 
instances when they are not effective, ‘‘Effectiveness and 
safety (of a vaccine) are the same thing. Will it protect me 
or will it not (against diseases)’’ (PC).
Other participants felt vaccines were even more important 
now that they are pregnant, ‘‘When I wasn’t pregnant, I’d also 
had my shots, but not with the same frequency and it wasn’t 
as important to me as it is now. Before, I’d get vaccinated and 
that was it, but now I know that it keeps the baby from getting 
sick’’ (SM). Reports from peers, or positive experiences 
of other pregnant women who were vaccinated, were also 
important influences on their perception of the effectiveness 
and safety of maternal immunisation.
Refusal of maternal vaccines as negligence
Most of the women did not report refusing maternal immu-
nisation. They were asked to think of reasons why pregnant 
women might refuse vaccination during pregnancy. Partici-
pants of this study commonly associated vaccine refusal with 
negligence, ‘‘There are women who say it’s pointless to get 
vaccinated, but they don’t think about their baby. Many chil-
dren are born with illnesses, and it’s not known if it’s because 
of something else (…) or because of the negligence (of not 
vaccinating)’’ (PC). To many of the participants, to have 
maternal vaccinations was to be responsible for preventing 
their new- borns from getting hurt: ‘The main reason to get 
vaccinated during pregnancy is to prevent some diseases that 
can hurt the baby in the future’’ (PC); ‘‘(To vaccinate) is the 
best prevention and I don’t want to be held responsible (for 
not vaccinating if the child were to get ill)’’ (PC).
To vaccinate during pregnancy was also perceived by 
participants as a mother’s act of love towards her baby 
and the community. When asked why a mother, having 
access to immunisation, would refuse to vaccinate during 
pregnancy, one participant said, ‘‘Those who do not vacci-
nate don’t love themselves, or anyone else’’ (PC).
Vaccine refusal as negligence was not only associated 
with maternal vaccination, but also with childhood vacci-
nation, ‘‘I’ve seen cases of negligence. There are mothers 
who don’t get their children vaccinated. My sister- in- law’s 
children weren’t vaccinated, and her daughter fell ill 
because of a virus and in the hospital, they realized she 
wasn’t getting her shots and they scolded her … They 
nearly called social services because this is penalized here 
in Panama’’ (PC).
Sources of information and influences on decision-making
Most participants reported intense information seeking 
behaviour regarding their overall health, particularly 
using the internet. As one said, ‘‘I search everything, I 
am a detective online’’ (PC). Interviewees reported using 
apps such as mi embarazo (my pregnancy), but not group 
chat technologies (e.g., WhatsApp or Facebook groups), 
to connect with peers or participate in online discussions.
Even with a high internet usage, most of the preg-
nant women reported consulting with HCPs before 
making health- related decisions. HCPs were identified 
as the most trustworthy source of information by several 
participants, and many reported fact- checking informa-
tion harvested online. While the internet is mostly used 
for overall health questions, any vaccine- related ques-
tions tend to be directly asked to their HCPs. Whenever 
getting information online or from non- medical sources 
(e.g., family, husband), many participants again reported 
seeking advice from their HCPs over the matter. Partic-
ipants reported that husbands, when asked about these 
issues, usually advised them to revert to their HCP for 
guidance. Even though the HCP remained a focal point 
for information about maternal vaccination for many of 
the participants, a few women mentioned concerns and 
misconceptions that arose from information they came 
across online, particularly from YouTube.
Importance of HCP recommendations of maternal 
immunisation
Among most of the women, HCP recommendations were 
cited as one of the main drivers of maternal vaccination. 
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Some women reported that they received limited infor-
mation from their HCPS about specific vaccines, but that 
the HCP recommendation was still enough to convince 
them to vaccinate. As one explained, ‘‘No, I didn’t (get 
a detailed explanation about the vaccine). Of course (I 
would have liked more information). But I got the vaccine 
because those were the doctor’s orders’’ (PC). Another 
commented, ‘‘If the nurse says I should get vaccinations I 
get them, I don’t have to talk to anyone else’’ (PC).
Sometimes the high reliance on the HCP recommen-
dation, or lack thereof, was reported by several women 
as occasionally driving them away from maternal vacci-
nation: ‘‘(I have not been vaccinated while pregnant) 
because the doctor hasn’t told me to’’ (SM); ‘‘I’m not 
going to get vaccinated if I’m not told to (by my HPCs)’’ 
(PC); ‘‘I suspected I was going to get vaccinated, but I 
was just going to wait and see what the doctor says. (…) I 
haven’t asked’’ (PC); ‘‘I know they (vaccines) are essential 
during pregnancy, but (my doctor) hasn’t ordered that 
yet’’ (SM).
The recommendations of HCPs were also cited as 
reasons to trust that it is safe to vaccinate during preg-
nancy: ‘‘I’m sure the doctor will not give you a shot that 
is not safe for us’’ (PC); ‘‘The doctors offer it to me and 
that’s why I feel safe’’ (SM); ‘‘Most of them are safe, I’m 
sure the doctor isn’t going to give you a shot that will harm 
your baby. 99% of them are safe’’ (SM) and ‘‘If the doctor 
says vaccines are safe, then I see no problem’’ (PC).
Religious compatibility with vaccination and implication for 
indigenous communities
Most participants did not see their religious beliefs as an 
impediment to maternal vaccination or immunisation 
in general. In fact, most did not believe science and reli-
gion should be mixed. As one commented, ‘‘Religion and 
vaccines have nothing to do with the other’’ (PC). Others 
noted: ‘‘I’m not religious, but I do believe in God, and I 
don’t think it affects my trust in vaccination’’ (SM); ‘‘As 
science makes progress, doctors have discovered medi-
cines and injections to help prevent diseases, but that has 
nothing to do with religion’’ (PC) and ‘‘My religion and 
culture have nothing to do with vaccines. Nothing at all’’ 
(PC).
On occasion, participants frame their own religious 
beliefs in a way that encourages vaccination. One woman 
explained, ‘‘(The Bible) says God has put doctors and 
nurses (to care for us). That’s biblical because if you feel 
ill, you must pray, and the Bible says that through the 
wounds of Christ we are healed, but the Bible also says 
that there are doctors and nurses, and God has put them 
there’’ (PC).
Although participants themselves did not see their own 
religious beliefs as incompatible with maternal immunisa-
tion, many women surveyed mentioned other traditional 
cultural and religious practices that view vaccination 
differently. Such practices would be predominant mostly 
in rural settings, particular within indigenous territories, 
or comarcas. One mother- to- be discusses this issue, ‘‘(What 
stops some women getting vaccinated) are myths … for 
example, religion. There are people who believe vaccines 
go against their religious beliefs. (…) many women said 
that their religion taught them to go to a healer and not 
to a healthcare centre and that’s why many children died’’ 
(PC). Another commented, ‘‘There are many illnesses 
that affect adults and children in rural areas (…) and 
some indigenous people’s religion does not allow vacci-
nation’’ (PC).
Fragmentation in access to maternal vaccination
Women’s reports of their experiences pursuing vacci-
nation pointed to access barriers (e.g., cost and avail-
ability) to maternal immunisation in Panama City and 
San Miguelito. Study participants reported mixed use 
of private and public services for both maternal health 
services and immunisation.
Among participants, there were discrepant reports 
about the quality and availability of maternal health 
public services and different reasons for using private 
versus public health services. There were reports of good 
access in public services, ‘‘I chose the (public) healthcare 
centre because my mother told me they’re good and (…) 
I stayed there. (…) they’re reliable’’ (PC). Still, at times 
public services were described as insufficient or difficult to 
access. One mother discussed her difficulties in accessing 
public healthcare, ‘‘It’s a rather tiresome process (…) 
first they give you an appointment for a gynaecologist 
to see you and another appointment for an ultrasound. 
It’s not like a private clinic (…), It’s a bit complicated. 
I go to both places for my tests’’ (PC). In cases where 
mothers have economic access to private clinics, it was not 
uncommon for participants to switch to private services to 
get better provision or choose their doctor, ‘‘(I changed 
doctors because) I felt she wasn’t involved, and I was 
worried about my family’s medical history, and she didn’t 
seem concerned (…). So I decided to switch to a doctor 
that meet my needs. I feel more at ease (now that I go to) 
a private clinic’’ (PC). Or ‘‘The female doctor I went to 
was not too involved with me (…) I wanted someone who 
was more serious or took more interest. I am now using 
private (health services)’’ (PC).
Reports of access to maternal vaccination followed a 
similar pattern, with a mixed use of private and public 
health services. A few women reported being directed 
from private clinics towards public health services to get 
vaccinated, to avoid paying vaccines out- of- pocket, ‘‘The 
doctor tells me at private clinic that I need vaccine. She 
tells me to go to (the public) health centre so I don’t 
have to pay’’ (PC). In contrast, others mention having 
to pay for immunisation in private clinics and reported 
difficulties of access due to costs, ‘‘Some vaccines you 
have to pay for and people can’t afford’’ (PC). Another 
participant cited physical access as a reason for not 
vaccinating during pregnancy, ‘‘(Some women don’t 
vaccinate) because of access. They can’t get there to the 
appointments’’ (SM).
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Concerns, misconceptions and rumours about maternal 
vaccination
While most participants reported a positive regard for 
maternal immunisation, some presented concerns with 
recurring themes related to vaccine safety. These concerns 
were particularly prominent in focus groups discussions, 
where women were encouraged to freely associate words 
that came to mind when presented with images of women 
getting vaccinated while pregnant.
A repeated concern was that vaccines could lead to 
miscarriages: ‘‘Will it harm the baby? Not the mother, but 
the baby because there are vaccines that result in miscar-
riage’’ (PC); ‘‘I am scared because vaccines can lead to 
miscarriage’’ (PC); ‘‘Especially during my first pregnancy. 
I saw people who said they were four months pregnant 
or that they felt sick and got a shot and miscarried. … or 
they didn’t know they were pregnant and got a vaccine 
and had a miscarriage’’ (PC). Another recurrent concern 
was that vaccines could lead to allergic reactions which 
might be harmful for the fetus: ‘‘I might think is this 
vaccine going to be harmful for my baby? Am I allergic’’ 
(SM); ‘‘It might not be safe because for a specific reason 
and you might be allergic’’ (SM).
In stark contrast to overall confidence in maternal 
immunisation, one mother discussed her suspicions 
around maternal immunisation, ‘‘We are the guinea pigs, 
they test vaccines on us before sending to South America’’ 
(SM). And another participant reported mistrust due to 
information gathered online, ‘‘I investigate a lot. I’ve 
seen on YouTube that many vaccines are made of animal 
organs and there are vaccines, such as the polio vaccine, 
that’s responsible for HIV in humans … I’m a bit doubtful 
when it comes to that one, but if made of other compo-
nents, then children need to get vaccinated’’ (PC).
DISCUSSION
This study identified themes associated with maternal 
vaccine confidence in Panama. The results suggest an 
overall positive sentiment towards maternal immunisa-
tion in Panama City and San Miguelito. Due to a height-
ened sense of vulnerability to infectious diseases when 
pregnant, perceptions of vaccine safety and effectiveness 
appeared to be closely linked. Among some of the inter-
viewees, a vaccine was considered safe when it effectively 
protects pregnant women against infectious diseases.
There was an overall perception of maternal immu-
nisation as a social norm, one that is expected of them. 
When asked about their decision- making process, most 
pregnant women reported believing that there is no deci-
sion to be made. Getting all the vaccines recommended 
for pregnancy is part of their routine healthcare. Yet, 
the pregnant women interviewed in this study reported 
a high involvement of their husbands and partners in 
their overall health decision- making. To that end, future 
health policy and communications for maternal immuni-
sation should consider targeting both pregnant women 
and their partners in official strategies.
In this study, participants reported high levels of 
information- seeking behaviour, particularly online. 
This is not unique to this sample and has been identi-
fied as occurring in different settings among pregnant 
women.16 17 Still, despite looking online for information 
about their pregnancy, most of the pregnant women in 
the present study cited their HCPs as their most trusted 
source of information and repeatedly reported cross- 
checking online information with them. Moreover, when 
looking for information on maternal immunisation, most 
participants stated they generally relied on their HCPs for 
advice.
The importance of HCP recommendations has been 
previously identified as one of the main drivers of vacci-
nation in pregnant women.9 18–21 While trust in the HCPs 
is positive and desirable, participants did not report any 
other public health efforts, such as government communi-
cation campaigns, that could inform them of the need of 
a maternal vaccination. Consequently, many participants 
of this study said they would consider maternal vaccina-
tion only if directly prescribed by their HCPs. This is of 
concern as many participants in this study reported not 
having received this recommendation, raising concerns 
about consistency of recommendation from HCPs in the 
two cities included in this study. High levels of depen-
dency on HCP recommendations, alongside a patchy 
health system, mean that other policy strategies (such as 
targeted communication campaigns) may be needed to 
ensure that the majority of pregnant women are reached.
In this study, participants reported a mixed use of public 
and private maternal health services, including for immu-
nisation. Pregnant women discussed difficulties in access, 
either due to availability of vaccines in public services, 
physical barriers (i.e., not managing to reach services) 
or financial impediments. In situations where access was 
possible, the route to maternal immunisation was, at 
times, unclear. Considering women in this sample were 
living in urban regions, Panama City and San Miguelito, 
this raises concerns for maternal immunisation access in 
rural and indigenous areas which are reported to have an 
even patchier and more precarious access to the health-
care system.22 23
Indigenous populations were not interviewed, but the 
offer of healthcare services to this population is known to 
be inadequate. Many of these regions are geographically 
isolated by mountainous dirt roads and powerful rivers, 
making the delivery of medical care and routine vaccina-
tions difficult. For some of these indigenous groups, up 
to 90% live in rural areas in reservations (or comarcas), 
while the majority of individuals in other groups live in 
urban areas within the provinces.22 Prior studies have 
shown that high rates of extreme poverty and illiteracy 
are common among indigenous populations in Panama, 
and disparities in maternal mortality rates and access 
to healthcare persist despite efforts to improve health-
care access in these remote regions,5 7 particularly when 
minority groups are extensively reported to have lower 
levels of trust in HCPs and the healthcare system, this 
7Simas C, et al. BMJ Open 2021;11:e044903. doi:10.1136/bmjopen-2020-044903
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picture of maternal immunisation confidence is likely to 
be different in other regions in Panama, particularly in 
the comarcas.
While there is an overall positive sentiment towards 
maternal immunisation, some participants mentioned 
concerns and misconceptions. These concerns were 
mostly shared during free association exercises in the focus 
groups among their peers. The most common concerns 
raised were related to a fear of miscarriage, cited by many, 
but some also reported being generally suspicious of 
maternal immunisations (e.g., fear that women are being 
experimented on). Women have also reported that not 
much information was given to them prior to maternal 
immunisation—it only informed them that vaccination 
was necessary. HCPs should aim to provide more infor-
mation and stimulate women to openly discuss with them 
any concerns they might have regarding immunisation 
and remain alert for any rumours, misinformation or 
other concerns expressed by women considering vaccina-
tion during pregnancy. Future studies should investigate 
the association between economic, educational, marital 
or professional status and maternal vaccine confidence.
Limitations
This study has limitations. First, despite a large sample 
of participants, the research was conducted in two main 
urban centres in Panama and did not include partici-
pants of indigenous and rural settings. Second, there is a 
marked gap in public health services between urban, rural 
and indigenous regions in Panama; indigenous and rural 
regions experience weaker access to maternal immunisa-
tion, as well as lower levels of both vaccine literacy and 
trust in health services. Third, qualitative study findings 
are not essentially generalisable but instead investigate 
practices and experiences which may not be captured in 
quantitative studies.
CONCLUSION
The government of Panama has promoted maternal 
immunisation as an important strategy to increase 
maternal health in the country. Continued success of a 
maternal immunisation programme depends on high 
coverage, which is linked to attitudes and acceptance 
among target populations. Data from this qualitative 
study suggest that there is a high level of positive atti-
tudes towards maternal vaccines among pregnant women 
in Panama. The acceptability of maternal immunisation 
was high in the sample studied. Pregnant women’s will-
ingness to receive maternal immunisations even when 
information provided was scarce was suggestive of high 
levels of trust in HCPs. Even so, HCPs and health offi-
cials should remain alert to any rumours, misinforma-
tion and concerns expressed by pregnant women. Many 
participants reported difficulties in accessing maternal 
vaccination, pointing to financial and physical issues 
which merit further investigation. Finally, future studies 
of maternal immunisation acceptance in Panama should 
aim to generate evidence which can help build policies 
that cater to rural and indigenous populations.
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